Traversal is used by industry-leading enterprise customers within their mission-critical technology environments, reducing mean time to recovery (MTTR) by an average of 40% across its enterprise clients through high-accuracy root cause analysis and automated alert triage. New York City-based Traversal came out of stealth in June 2025 after announcing $48M in funding led by Kleiner Perkins and Sequoia.